Suchergebnisse

Suvremeni pogled na umiranje obilježen je nizom neizvjesnih i teških pitanja koja proizlaze iz kliničkoga konteksta, pravne i bioetičke domene donošenja teških egzistencijalnih odluka vezanih uz posljednje životne trenutke, a napose s obzirom na medicinske intervencije izbora "skrbi na kraju života". Taj korak zahtijeva punu racionalnost slobodne autonomije, koja u određenim trenucima može biti znatno narušena gubitkom fizičkih i/li mentalnih sposobnosti, uvjetovanih pojedinim bolestima. Stoga bi bolesnici trebali imati zakonodavnu mogućnost jasno priopćiti svoje želje u vezi sa zahtijevanim tretmanom ili njegovim distanazijskim povlačenjem u unaprijed pripremljenim smjernicama anticipiranih medicinskih odredbi bioloških oporuka za (ne)postupanje ili imenovanje surogatnog opunomoćenika kao zastupnika u (ne)izboru liječenja u slučaju ograničene sposobnosti odlučivanja. Potpisana biološka oporuka mogla bi uvelike pridonijeti pozitivno dostojanstvenijom modusu samodeterminiranog načina umiranja, poštujući "kulturu života", sukladnog onom koji je odabir autonomnih pacijentovih vrijednosti skrbi na kraju života, koji često mogu ući u koliziju iz heteronomne perspektive surogatnih odlučitelja. Biološkim bi se oporukama višestruko nadvladale i teškoće kliničkih dilema egzistencijalnih odluka: liječnicima bi se olakšao odabir skrbi u hitnim planovima zdravstvene njege u kriznim situacijama; pacijentima bi pružale jamstvo provedbe njihova samoodređenja; dok bi surogatne odlučitelje uvelike oslobodili pritiska odgovornosti. ; A contemporary view of death is characterized by a sequence of uncertain and difficult questions arising from the clinical context, out of the legal and bioethical domains of taking difficult existential decisions related to the last moments of human life. This step requires a full rationality of free autonomy, which can be significantly disturbed by the loss of mental ability, conditioned by certain illnesses in certain moments. Therefore, patients should have a legislative opportunity to clearly ...

The European Parliament adopted the Directive 2017/828 as regards the encouragement of long-term shareholder engagement that grants shareholders to hold the right to vote on the remuneration policy for employees and directors. Following the collapse of large companies in the USA and common agency problem, the intent of regulators on capital markets was to ensure preconditions for stable companies, so remuneration policies were prescribed by the recommendations and through corporate governance mechanisms, such as is say on pay. In order to align interests of the companies and their directors, remuneration policy was recognized as one of the key instruments introduced by the EU legislator for financial institutions, primarily investment funds and banks. The implementation of the Directive into national legislation is mandatory, so for the first time the regulator gives shareholders the right to decide on the remuneration of directors, it gives them the option of setting the framework within the pay of directors is to be held and proposing public disclosure of remuneration policy. One of the major issues that will be imposed by the new Directive will be how and to what extent the decision on the remuneration of directors, will be left to the shareholders to vote at the general meeting. The authors in this paper analyze new system on remuneration policies, opportunities and obstacles that companies may face, as well as the challenges imposed to directors, in the implementation of the Directive in national legislation and practice.

Zamjensko majčinstvo, kao najsloženija metoda medicinski pomognute oplodnje i posljednje sredstvo u borbi protiv neplodnosti, u svijetu pobuđuje velike rasprave, kucajući i na vrata našega zakonodavstva, medicine i pravosuđa, što je osnovni razlog za cjelovito promatranje takve pojave s bioetičkoga motrišta kako bi se ukazalo na kompleksne moralne posljedice koje zamjensko majčinstvo sa sobom nosi u složenim odnosima (zamjenske majke, supružnika, naručiteljskoga para, djeteta). ; Surrogate motherhood as the most complex method of medically assisted reproduction and the last tool in the fight against infertility, stirs great debates around the world, knocking also on the doors of our own legislation, medicine and judiciary, which is the main reason for a comprehensive analysis of this phenomenon from a bioethical point of view in order to show the complex moral consequences that follow surrogate motherhood in the complex relationships (of the surrogate mother, spouses, the client couple, the child).